Our product development milestones help us evaluate the progress of our investments in line with pharmaceutical and biotech industry standards. Some of these milestones are called Stage-Gates, which also serve as major decision or check points for continued investment. The Stage-Gate idea-to-launch model is an international industry standard for managing decision-making for new product innovation.
“Graduating from” or moving through a Stage-Gate indicates that a drug, vaccine, or diagnostic candidate is one step closer to final approval and that it warrants further investment. These Stage-Gates are based on the methodology for drug development and can also be used as a reference for development of a vaccine or diagnostic.